Sennosides and Docusate Sodium
Active substance: SENNOSIDES, DOCUSATE SODIUM
TABLET · SENNOSIDES 8.6 mg/1, DOCUSATE SODIUM 50 mg/1
United StatesActive
Marketing holder: Asclemed USA, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- SENNOSIDES · 8.6 mg/1
- DOCUSATE SODIUM · 50 mg/1
Registration
- Registration number
- 76420-918
- Registration status
- Active
- Dispensing
- Over the counter
- Route
- ORAL
Sources
- product · openFDA NDC · 76420-918 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 76420-918 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 76420-918 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 76420-918 · Verified 2026-10-09 · open in source